Bayer shares after legal battle won to limit liability arising from claims that herbicide Roundup causes cancer %It increased by 12.38 to €29.67.
The plaintiff, Pennsylvania-based landscaper David Schaffner, claimed that Bayer ⁇ in's Monsanto unit violated state law by not placing a cancer warning on Roundup ⁇ 's label.
But a U.S. appeals court said federal laws regulating the insecticide's warning label were ahead of Pennsylvania's laws.
According to Reuters, Bayer stated that he was satisfied with the decision and continued to argue that Roundup and its active ingredient glyphosate were safe, and that the brand continued to stand fully behind it.
In June 2018, the German pharmaceutical company completed its acquisition of agricultural company Monsanto ⁇ for $63 billion (approximately €57 billion).
Bayer ⁇ in's share value in the past 12 months has been approximated following the firm's exposure to billions of euros in compensation for mismanaging Monsanto ⁇ 's herbicide product. is down.
The sale of Roundup, one of the most widely used herb medicines in the USA, for home use was phased out by Bayer last year.
